Want to create an interactive transcript for this episode?
Podcast: Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Episode: Tirzepatide (Mounjaro) Pharmacology Podcast
Description: On this episode I discuss the pharmacology of tirzepatide. Iām appreciative of Derek Borkowski who operates Pyrls for providing a free PDF of the 2023 ADA Diabetes Guidelines when you subscribe for an account at Pyrls.com/rlp ā Tirzepatide makes its first appearance in the diabetes guidelines for its ability to promote weight loss.
Tirzepatide is a combination GIP and GLP-1 agonist that is currently indicated for diabetes with reductions of A1C in the range of about 2 points.
Much like GLP-1 agonists, tirzepatide can cause GI upset and other gastrointestinal adverse effects like diarrhea.
<...